Kevin D Freeman insider trades
Open-market stock purchases and sales by Kevin D Freeman, Unknown at Galectin Therapeutics Inc, from SEC Form 4 filings since Jun 2, 2011.
Track record: 68% of 31 scored buys are up 5% or more since purchase, averaging +28%.